NDRA ENDRA Life Sciences
- 0.2060
- +0.0035+1.73%
- 0.2020
- -0.0040-1.94%
ENDRA Life Sciences News
DEFA14A: Others
DEF 14A: Definitive information statements
PRE 14A: Preliminary proxy statements relating to merger or acquisition
4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)- UBS Group AG
3/A: Initial statement of beneficial ownership of securities (Amendment)- UBS Group AG
4: Statement of changes in beneficial ownership of securities-10% Owner UBS Group AG
3: Initial statement of beneficial ownership of securities-10% Owner UBS Group AG
8-K: Current report
8-K: ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
8-K: Current report
3: Initial statement of beneficial ownership of securities-Officer Jacroux Richard
10-Q: Q2 2024 Earnings Report
8-K: Current report
8-K: Current report
DEFA14A: Others
8-K: Current report
DEF 14A: Definitive information statements
DEFA14A: Others
ARS: Annual Report to Security Holders
SC 13G: Statement of acquisition of beneficial ownership by individuals-S.H.N. Financial Investments Ltd.(9.99%)
Analysis
Price Target
No Data
No Data